| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/01/2008 | CN100421692C Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate |
| 10/01/2008 | CN100421691C Chinese-western medicine composition for treating hepatitis |
| 10/01/2008 | CN100421688C Synergistic medicinal composition containing thiopronin and Chinese medicine extract |
| 10/01/2008 | CN100421686C Chinese-western medicine composition for treating hepatitis |
| 10/01/2008 | CN100421683C Composite red sage root micro-capsules for cardio-cerebral diseases and its preparing method |
| 10/01/2008 | CN100421681C Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 10/01/2008 | CN100421679C Methods and compositions for control of coccidiosis |
| 10/01/2008 | CN100421675C Zinc replenisher with control released zinc and its preparing method and use |
| 10/01/2008 | CN100421673C Pharmaceutical use of glycoconjugates CHB for preventing and treating avian flu |
| 10/01/2008 | CN100421672C Compound lentinan preparation for antitumour and its preparing method |
| 10/01/2008 | CN100421671C Medicinal composition for treating cardio-cerebro-vascular diseases |
| 10/01/2008 | CN100421670C Amikacin paste and preparing method and use |
| 10/01/2008 | CN100421669C A low-sugar granule for treating infants cold and preparation method thereof |
| 10/01/2008 | CN100421668C Medicine formulation for left-eyed flounder and right-eyed flounder to prevent and control a scites |
| 10/01/2008 | CN100421667C Method for treating and preventing hyperparathyroidism |
| 10/01/2008 | CN100421666C Epristeride slow release preparation |
| 10/01/2008 | CN100421665C Mitotic kinesin inhibitors |
| 10/01/2008 | CN100421664C Medication for treating convulsion and falling sickness |
| 10/01/2008 | CN100421663C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine A2A receptor antagonists |
| 10/01/2008 | CN100421662C Disperese torasemide tablet and its prepn and application |
| 10/01/2008 | CN100421661C Method of inducing cancer cell death and tumor regression |
| 10/01/2008 | CN100421660C Composition for the treatment of vitiligo |
| 10/01/2008 | CN100421659C Compositions and methods for lowering plasma lipoprotein (a) and risk factors of cardiovascular diseases |
| 10/01/2008 | CN100421658C Medication for treating coronary heart disease and angina |
| 10/01/2008 | CN100421657C Acidum transamicum sodium chloride injection liquid preparation method |
| 10/01/2008 | CN100421656C Methods of treating injuries of the nervous system associated with hemorrhage |
| 10/01/2008 | CN100421655C Pharmaceutical composition for stabilizing ambroxol hydrochloride granula |
| 10/01/2008 | CN100421654C Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence |
| 10/01/2008 | CN100421653C Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
| 10/01/2008 | CN100421652C Pharmaceutical compsns. of conjugated estrogens and methods for their use |
| 10/01/2008 | CN100421648C Hydrocortisone clyster agent and method for preparing the same |
| 10/01/2008 | CN100421565C Oil/fat composition |
| 10/01/2008 | CA2654898A1 New chemical compounds |
| 09/30/2008 | USRE40525 Hepatitis C inhibitor tri-peptides |
| 09/30/2008 | US7430476 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 09/30/2008 | US7429679 good physicochemical properties(solubility, non-hygroscopicity and stability); depression, Parkinson's disease, obesity, insulin-independent diabetes mellitus, epilepsy |
| 09/30/2008 | US7429677 3'-methylene-bis(6-((4-methylphenyl)sulfonylamino)-benzoic acid) , or its N-oxide form, salt, stereoisomeric form, racemic mixture, prodrug or ester; block HIV from entering the human cell by interfering with various phases of attachment and fusion between HIV and the cell; Anti HIV agent; AIDS |
| 09/30/2008 | US7429674 Alkylating an imine containing acid or ester group and two phenyl rings with a fluorotriflate electrophile to form a substituted imine, forming an azolactone, enzymetically opening the azolactone with a hydrolytic enzyme such as lipase B to form alkylamine, deprotecting alkylamide with an oxidizing agent |
| 09/30/2008 | US7429673 TRPV1 agonists, formulations containing them and uses thereof |
| 09/30/2008 | US7429670 antagonists of the GlyR (glycine receptor); diterpene trilactones; cage-like skeleton; neuroprotectant, antioxidant, antiproliferation agent, cognition activator; parallel solution phase synthesis |
| 09/30/2008 | US7429666 Pyridine analogs as C5a antagonists |
| 09/30/2008 | US7429663 7-(Pyrimidin-4-yl)-Imidazo[1,2-a]Pyrimidin-5(1H)-ones as GSK3β inhibitors |
| 09/30/2008 | US7429659 Isopropyl-piperazin-1-yl)-(5-piperidin-1-ylmethyl-furan-2-yl)-methanone; 5-(4-Fluoro-piperidin-1-ylmethyl)-furan-2-yl]-(4-isopropyl-piperazin-1-yl)-methanone, fumarate salt; insomnia, attention deficit hyperactivity disorders, learning disorders, cognitive dysfunction, eating disorders, obesity |
| 09/30/2008 | US7429656 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference |
| 09/30/2008 | US7429643 POSH nucleic acids, polypeptides and related methods |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429617 Phenoxyalkycarboxylic acid derivatives in the treatment of interstitial cystitis |
| 09/30/2008 | US7429616 neoplastic diseases; synthetic intermediate compounds |
| 09/30/2008 | US7429615 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
| 09/30/2008 | US7429614 Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus |
| 09/30/2008 | US7429613 Preparing 5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3hydroxyl-1-pentanoic acid 7 by reacting aldehyde with 2-hydroxy-1,2,2-triphenylethyl acetate and a chelating cosolvent; hydrolysis; carboxylation by reaction with base; salt formation, purification |
| 09/30/2008 | US7429612 Indoline compound and medicinal use thereof |
| 09/30/2008 | US7429611 Indole inhibitors of 15-lipoxygenase |
| 09/30/2008 | US7429610 diindole compounds as anticancer agents; potentiation; effective against estrogen-dependent, estrogen-independent, drug-resistant and/or metastasized cancers |
| 09/30/2008 | US7429609 Pyrazole compound and medicinal composition containing the same |
| 09/30/2008 | US7429608 Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments |
| 09/30/2008 | US7429607 5-HT2B receptor antagonists |
| 09/30/2008 | US7429606 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents |
| 09/30/2008 | US7429605 Phenylpyridine derivatives |
| 09/30/2008 | US7429604 Six-membered heterocycles useful as serine protease inhibitors |
| 09/30/2008 | US7429603 C-fms kinase inhibitors |
| 09/30/2008 | US7429602 Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva |
| 09/30/2008 | US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents |
| 09/30/2008 | US7429600 Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
| 09/30/2008 | US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 09/30/2008 | US7429598 Spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| 09/30/2008 | US7429597 Heterobicyclic compound such as quinazoline anticoagulants and factor X inhibitors |
| 09/30/2008 | US7429596 Oxidoreductase inhibitors; anticancer agents; antiinflammatory agents |
| 09/30/2008 | US7429595 Inhibiting cyclin-dependent kinase complexes including cdk1/cyclin B, cdk2/cyclin E and cdk4/cyclin D1; preventing apoptosis |
| 09/30/2008 | US7429594 Substituted heterocyclic compounds and methods of use |
| 09/30/2008 | US7429593 Utilities of amide compounds |
| 09/30/2008 | US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 09/30/2008 | US7429591 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(2-Amino-6-chloro-phenyl)-piperazin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 09/30/2008 | US7429590 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry |
| 09/30/2008 | US7429589 4-Morpholino-2-nitroanisole; antidepressant; reacting Morpholinoanisole, Nitric Acid Salt with sulfuric acid and after dilution with water treating the solution with base to reach a pH of greater than 10; exothermic reaction; safer nitration processes and better control of chemistry |
| 09/30/2008 | US7429588 Crystalline isoxazole derivative and medical preparation thereof |
| 09/30/2008 | US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 09/30/2008 | US7429586 Non-imidazole aryloxyalkylamines |
| 09/30/2008 | US7429585 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups |
| 09/30/2008 | US7429584 Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders |
| 09/30/2008 | US7429583 e.g. 8-{2-[1,1-dimethyl-3-(6-methyl-2-oxo-2,3-dihydro-benzimidazol-1-yl)-propylamino]-1-hydroxy-ethyl}-6-hydroxy-4H-benzo[1,4]oxazin-3-one; adrenoreceptor modulator (agonist); respiratory system diseases: COPD, asthma, cystic fibrosis, bronchitis, bronchiectasis; sustained release |
| 09/30/2008 | US7429582 e.g. N,N-dimethyl-1-[6-(1-naphthylsulfonyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indazol-2-yl]-methanamine; serotonin receptor antagonist; antidepressant, epilepsy, schizophrenia, hyperactivity |
| 09/30/2008 | US7429581 Pyrazole-derivatives as factor Xa inhibitors |
| 09/30/2008 | US7429580 Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss |
| 09/30/2008 | US7429579 antagonism/inhibition, of the D3 receptor; substance abuse. |
| 09/30/2008 | US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation |
| 09/30/2008 | US7429577 Administering antipsychotic agent and chromium picolinate for cognition treatment with psychotic drugs |
| 09/30/2008 | US7429576 treatment for osteoporosis, hypercholesterolemia, hyperlipidemia, atherosclerosis, breast cancer, endometrial cancer, ovarian cancer and uterine cancer while minimizing undesirable side effects |
| 09/30/2008 | US7429575 Cosmetics; skin disorders; dermatology |
| 09/30/2008 | US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use |
| 09/30/2008 | US7429573 Osteoporosis |
| 09/30/2008 | US7429572 Modified fluorinated nucleoside analogues |
| 09/30/2008 | US7429571 4-Amino-7- beta -(2'-C-methyl-D-ribofuranosyl)-furo[3,2-d]pyrimidine; anticancer agents |
| 09/30/2008 | US7429570 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
| 09/30/2008 | US7429569 Compositions and methods for the regulation of homocysteine levels within the body |
| 09/30/2008 | US7429568 Antidiabetic agents; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; hyperglycemia, obesity; 3-(6-O-ethoxycarbonyl- beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole |
| 09/30/2008 | US7429565 Antiviral phosphonate analogs |
| 09/30/2008 | US7429489 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 09/30/2008 | US7429488 Method for processing lipoaspirate cells |
| 09/30/2008 | US7429483 Use of nerve growth factor for the storage, culture or treatment of cornea |